微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.59% | -28.05% | -69.66% | 66/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 5.24% | -43.78% | 4.59% | 58/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 5.01% | -30.51% | 22.79% | 62/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 4.08% | -22.14% | 84.62% | 43/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 2.21% | -27.3% | -76.29% | 50/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 9.32% | -12.16% | 29.26% | 32/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 7.21% | -20.33% | 37.6% | 47/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 5.24% | -10.73% | 72.37% | 35/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 3.04% | -15.32% | -71.35% | 32/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 10.61% | 8.49% | 17.24% | 27/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 9.05% | 16.47% | 54.17% | 29/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 5.87% | 26.24% | 63.51% | 29/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 3.59% | 16.94% | -63.29% | 24/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 9.78% | 12.8% | 25.87% | 44/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 7.77% | -9.02% | 67.1% | 47/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 4.65% | -16.67% | 51.47% | 50/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 3.07% | 0.99% | -64.59% | 35/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 8.67% | -7.77% | 1.52% | 49/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 8.54% | 5.96% | 53.05% | 47/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 5.58% | 9.63% | 83.55% | 48/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 3.04% | 5.56% | -67.66% | 41/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 9.4% | 3.07% | 16.63% | 58/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 8.06% | -6.06% | 58.35% | 47/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 5.09% | 4.09% | 76.74% | 55/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 2.88% | 3.97% | -68.42% | 35/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 9.12% | 0.55% | 6.29% | 61/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 8.58% | 13.34% | 75.46% | 42/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 4.89% | 2.52% | 76.53% | 49/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 2.77% | 2.21% | -69.46% | 37/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 9.07% | 16.43% | 19.82% | 55/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 7.57% | -8.57% | 58.7% | 40/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 4.77% | 12.5% | 76.01% | 43/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 2.71% | 5.86% | -65.21% | 36/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 7.79% | 49.81% | -5.92% | 67/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 8.28% | 78.83% | 95.28% | 40/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 4.24% | 81.2% | 65.63% | 56/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 2.56% | 139.25% | -50.77% | 34/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 5.2% | 137.44% | 12.31% | 81/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 4.63% | 38.62% | 97.86% | 53/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 2.34% | 178.57% | 118.69% | 64/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 1.07% | 37.18% | -51.14% | 56/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |